Member access

4-Traders Homepage  >  Shares  >  Amex  >  IGI LABORIGI       

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the development and commercialization of products for the dermatology market

IGI Laboratories, Inc. develops, manufactures and markets topical formulations.

The company sells generic topical pharmaceutical products under IGI label.

It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.

The company's products are used in a wide range of applications from cosmetics and cosmeceuticals to the prescription treatment of conditions like dermatitis, psoriasis, and eczema.

IGI Laboratories was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.

Number of employees : 52 persons.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Topical Formulations8.56100%18.22100% +53.01%
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States8.56100%18.22100% +53.01%
Managers
NameAgeSinceTitle
Jason Grenfell-Gardner, MBA392012President, Chief Executive Officer & Director
Joyce Erony542009Chairman
Sanjay Samudre-2013Operations Director
Jenniffer Collins, CPA452011Chief Financial Officer & Secretary
Kenneth J. Miller II, PhD-2012Senior Vice President-Research & Development
James C. Gale, MBA642009Independent Director
Narendra N. Borkar732009Independent Director
Bhaskar Chaudhuri, PhD592010Independent Director
Shareholders
NameShares%
Signet Healthcare Partners LLC 13,851,86126.4%
Amzak Capital Management LLC 4,574,5768.72%
Stephen J. Morris 3,004,6145.72%
Broadfin Capital LLC 2,100,0004.00%
First Light Asset Management LLC 1,194,3192.28%
Allianz Global Investors US LLC 1,115,1202.12%
D. E. Shaw & Co. LP 1,076,0912.05%
BlackRock Fund Advisors 1,020,4501.94%
The Vanguard Group, Inc. 620,3701.18%
Turner Investments LP 550,0001.05%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Surperformance© rating
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue)
Valuation -
Finances -
Profitability
Earnings quality -
Business Predictability
PER
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision
1 year Revenue revision -
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
GLAXOSMITHKLINE P..
BAYER AG
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
ELI LILLY AND CO
ABBOTT LABORATORI..
ACTAVIS PLC
SHIRE PLC
ALLERGAN, INC.
TEVA PHARMACEUTIC..
VALEANT PHARMACEU..
REGENERON PHARMAC..
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
Sector Pharmaceuticals
Company contact information
IGI Laboratories, Inc.
105 Lincoln Avenue
Buena, NJ 08310

Phone : +1.856.697.1441
Fax : +1.856.697.2259
Web : www.igilabs.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF